Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bredeson

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|December 16, 1998
A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantationI Bence-Bruckler, C Bredeson, H Atkins, et al.
Bone Marrow Transplantation|December 17, 2009
Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohortK Paulson, P Lambert, C Bredeson, et al.
Bone Marrow Transplantation|September 18, 2007
High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantationM D Seftel, M Ho, D Pruthi, et al.
Bone Marrow Transplantation|July 31, 2001
Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell doseC A Keever-Taylor, J P Klein, D Eastwood, et al.
Transfusion Medicine (Oxford, England)|January 31, 2018
Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping reviewM Monaghan, M Rizk, S Pilon, et al.
Bone Marrow Transplantation|August 16, 2002
Outpatient total body irradiation as a component of a comprehensive outpatient transplant programC Bredeson, G Perry, C Martens, et al.
Leukemia Research|September 16, 2019
Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literatureL Pi, J Rooprai, D S Allan, et al.
The New England Journal of Medicine|July 1, 1999
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant RegistryG Socié, J V Stone, J R Wingard, et al.
Bone Marrow Transplantation|February 21, 2006
Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemiaJ R Passweg, W S Pérez, M Eapen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletionC A Keever-Taylor, C Bredeson, F R Loberiza, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|December 16, 1998
A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantationI Bence-Bruckler, C Bredeson, H Atkins, et al.
Bone Marrow Transplantation|December 17, 2009
Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohortK Paulson, P Lambert, C Bredeson, et al.
Bone Marrow Transplantation|September 18, 2007
High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantationM D Seftel, M Ho, D Pruthi, et al.
Bone Marrow Transplantation|July 31, 2001
Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell doseC A Keever-Taylor, J P Klein, D Eastwood, et al.
Transfusion Medicine (Oxford, England)|January 31, 2018
Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping reviewM Monaghan, M Rizk, S Pilon, et al.
Bone Marrow Transplantation|August 16, 2002
Outpatient total body irradiation as a component of a comprehensive outpatient transplant programC Bredeson, G Perry, C Martens, et al.
Leukemia Research|September 16, 2019
Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literatureL Pi, J Rooprai, D S Allan, et al.
The New England Journal of Medicine|July 1, 1999
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant RegistryG Socié, J V Stone, J R Wingard, et al.
Bone Marrow Transplantation|February 21, 2006
Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemiaJ R Passweg, W S Pérez, M Eapen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletionC A Keever-Taylor, C Bredeson, F R Loberiza, et al.
Pageof 4